Arturi et al. showed reduced IGF1 levels in NAFLD patients and suggested, that hepatic insulin resistance may affect IGF1 levels by modulating GH-stimulated synthesis of hepatic IGF1 [97]. Here, GH1 is linked to metabolic dysfunction-associated steatotic liver disease.